| | | | | | Product | Package Size | EFP | CP | SB | DC | Composition | Registr. Holder | Category | | | | |
|---|
|
| | | IP | CI | | Olmesartan HCT Viatris
20/12.5 mg | 28 | 13.44 | 31.05 | k.A. | | Coated tablets: 2 Active Agents | Viatris Pharma GmbH | B | FB | | G |  |
| | | IP | CI | | Olmesartan HCT Viatris
20/12.5 mg | 98 | 40.04 | 59.95 | k.A. | | Coated tablets: 2 Active Agents | Viatris Pharma GmbH | B | FB | | G | |
| | | IP | | | Olmesartan HCT Viatris
20/25 mg | 28 | 13.44 | 31.05 | k.A. | | Coated tablets: 2 Active Agents | Viatris Pharma GmbH | B | FB | | G | |
| | | IP | | | Olmesartan HCT Viatris
20/25 mg | 98 | 40.04 | 59.95 | k.A. | | Coated tablets: 2 Active Agents | Viatris Pharma GmbH | B | FB | | G | |
| | | IP | | | Olmesartan HCT Viatris
40/12.5 mg | 28 | 16.67 | 34.55 | k.A. | | Coated tablets: 2 Active Agents | Viatris Pharma GmbH | ● B | FB | | G | |
| | | IP | | | Olmesartan HCT Viatris
40/12.5 mg | 98 | 51.09 | 72.00 | k.A. | | Coated tablets: 2 Active Agents | Viatris Pharma GmbH | B | FB | | G | |
| | | IP | | | Olmesartan HCT Viatris
40/25 mg | 28 | 17.11 | 35.05 | k.A. | | Coated tablets: 2 Active Agents | Viatris Pharma GmbH | B | FB | | G | |
| | | IP | | | Olmesartan HCT Viatris
40/25 mg | 98 | 51.09 | 72.00 | k.A. | | Coated tablets: 2 Active Agents | Viatris Pharma GmbH | B | FB | | G | |
| | SIP | IP | CI | | Olmetec Plus 20/12,5 | 28 Tablet(s) | 14.81 | 32.45 | 10 % | | Coated tablets: 2 Active Agents | Daiichi Sankyo
(Schweiz) AG | B / SL / SO | FB | | G | |
| | SIP | IP | CI | | Olmetec Plus 20/12,5 | 98 Tablet(s) | 44.03 | 64.05 | 10 % | | Coated tablets: 2 Active Agents | Daiichi Sankyo
(Schweiz) AG | B / SL / SO | FB | | G | |
| | SIP | IP | CI | | Olmetec Plus 20/25 | 28 Tablet(s) | 14.81 | 32.45 | 10 % | | Coated tablets: 2 Active Agents | Daiichi Sankyo
(Schweiz) AG | B / SL / SO | FB | | G | |
| | SIP | IP | CI | | Olmetec Plus 20/25 | 98 Tablet(s) | 44.03 | 64.05 | 10 % | | Coated tablets: 2 Active Agents | Daiichi Sankyo
(Schweiz) AG | B / SL / SO | FB | | G | |
| | SIP | IP | CI | | Olmetec Plus 40/12,5 | 28 Tablet(s) | 18.89 | 36.80 | 10 % | | Coated tablets: 2 Active Agents | Daiichi Sankyo
(Schweiz) AG | B / SL / SO | FB | | G | |
| | SIP | IP | CI | | Olmetec Plus 40/12,5 | 98 Tablet(s) | 56.17 | 77.20 | 10 % | | Coated tablets: 2 Active Agents | Daiichi Sankyo
(Schweiz) AG | B / SL / SO | FB | | G | |
| | SIP | IP | CI | | Olmetec Plus 40/25 | 28 Tablet(s) | 18.89 | 36.85 | 10 % | | Coated tablets: 2 Active Agents | Daiichi Sankyo
(Schweiz) AG | B / SL / SO | FB | | G | |
| | SIP | IP | CI | | Olmetec Plus 40/25 | 98 Tablet(s) | 56.17 | 77.20 | 10 % | | Coated tablets: 2 Active Agents | Daiichi Sankyo
(Schweiz) AG | B / SL / SO | FB | | G | |
| | | IP | CI | | Votum plus 20/12.5 | 28 Tablet(s) | 14.81 | 32.45 | 10 % | | Coated tablets: 2 Active Agents | A. Menarini GmbH | B / SL / SO | FB | | G | |
| | | IP | CI | | Votum plus 20/12.5 | 98 Tablet(s) | 44.03 | 64.05 | 10 % | | Coated tablets: 2 Active Agents | A. Menarini GmbH | B / SL / SO | FB | | G | |
| | | IP | CI | | Votum plus 20/25 | 28 Tablet(s) | 14.81 | 32.45 | 10 % | | Coated tablets: 2 Active Agents | A. Menarini GmbH | B / SL / SO | FB | | G | |
| | | IP | CI | | Votum plus 20/25 | 98 Tablet(s) | 44.03 | 64.05 | 10 % | | Coated tablets: 2 Active Agents | A. Menarini GmbH | B / SL / SO | FB | | G | |
| | | IP | CI | | Votum plus 40/12.5 | 28 Tablet(s) | 18.89 | 36.80 | 10 % | | Coated tablets: 2 Active Agents | A. Menarini GmbH | B / SL / SO | FB | | G | |
| | | IP | CI | | Votum plus 40/12.5 | 98 Tablet(s) | 56.18 | 77.20 | 10 % | | Coated tablets: 2 Active Agents | A. Menarini GmbH | B / SL / SO | FB | | G | |
| | | IP | CI | | Votum plus 40/25 | 28 Tablet(s) | 18.89 | 36.85 | 10 % | | Coated tablets: 2 Active Agents | A. Menarini GmbH | B / SL / SO | FB | | G | |
| | | IP | CI | | Votum plus 40/25 | 98 Tablet(s) | 56.18 | 77.20 | 10 % | | Coated tablets: 2 Active Agents | A. Menarini GmbH | B / SL / SO | FB | | G | |
| | | IP | CI | | Co-Olmesartan Spirig HC 20
mg/12,5 mg | 30 | 13.74 | 31.35 | 10 % | | Coated tablets: 2 Active Agents | Spirig HealthCare AG | B / SL / SG | FB | | G | |
| | | IP | CI | | Co-Olmesartan Spirig HC 20
mg/12,5 mg | 100 | 40.86 | 60.80 | 10 % | | Coated tablets: 2 Active Agents | Spirig HealthCare AG | B / SL / SG | FB | | G | |
| | | IP | CI | | Co-Olmesartan Spirig HC 20
mg/25 mg | 30 | 13.74 | 31.35 | 10 % | | Coated tablets: 2 Active Agents | Spirig HealthCare AG | B / SL / SG | FB | | G | |
| | | IP | CI | | Co-Olmesartan Spirig HC 20
mg/25 mg | 100 | 40.86 | 60.80 | 10 % | | Coated tablets: 2 Active Agents | Spirig HealthCare AG | B / SL / SG | FB | | G | |
| | | IP | CI | | Co-Olmesartan Spirig HC 40
mg/12,5 mg | 30 | 17.53 | 35.45 | 10 % | | Coated tablets: 2 Active Agents | Spirig HealthCare AG | B / SL / SG | FB | | G | |
| | | IP | CI | | Co-Olmesartan Spirig HC 40
mg/12,5 mg | 100 | 52.13 | 73.05 | 10 % | | Coated tablets: 2 Active Agents | Spirig HealthCare AG | B / SL / SG | FB | | G | |
| | | IP | CI | | Co-Olmesartan Spirig HC 40
mg/25 mg | 30 | 17.53 | 35.45 | 10 % | | Coated tablets: 2 Active Agents | Spirig HealthCare AG | B / SL / SG | FB | | G | |
| | | IP | CI | | Co-Olmesartan Spirig HC 40
mg/25 mg | 100 | 52.13 | 73.05 | 10 % | | Coated tablets: 2 Active Agents | Spirig HealthCare AG | B / SL / SG | FB | | G | |
| | | IP | CI | | Olmesartan Plus Sandoz 20
mg/12,5 mg | 28 | 13.46 | 31.05 | 10 % | | Coated tablets: 2 Active Agents | Sandoz
Pharmaceuticals AG | ● B / SL / SG | FB | | G | |
| | | IP | CI | | Olmesartan Plus Sandoz 20
mg/12,5 mg | 98 | 40.04 | 59.95 | 10 % | | Coated tablets: 2 Active Agents | Sandoz
Pharmaceuticals AG | ● B / SL / SG | FB | | G | |
| | | IP | CI | | Olmesartan Plus Sandoz 20
mg/25 mg | 28 | 13.46 | 31.05 | 10 % | | Coated tablets: 2 Active Agents | Sandoz
Pharmaceuticals AG | B / SL / SG | FB | | G | |
| | | IP | CI | | Olmesartan Plus Sandoz 20
mg/25 mg | 98 | 40.04 | 59.95 | 10 % | | Coated tablets: 2 Active Agents | Sandoz
Pharmaceuticals AG | ● B / SL / SG | FB | | G | |
| | | IP | CI | | Olmesartan Plus Sandoz 40
mg/12,5 mg | 28 | 17.17 | 35.05 | 10 % | | Coated tablets: 2 Active Agents | Sandoz
Pharmaceuticals AG | ● B / SL / SG | FB | | G | |
| | | IP | CI | | Olmesartan Plus Sandoz 40
mg/12,5 mg | 98 | 51.08 | 72.00 | 10 % | | Coated tablets: 2 Active Agents | Sandoz
Pharmaceuticals AG | ● B / SL / SG | FB | | G | |
| | | IP | CI | | Olmesartan Plus Sandoz 40
mg/25 mg | 28 | 17.17 | 35.10 | 10 % | | Coated tablets: 2 Active Agents | Sandoz
Pharmaceuticals AG | B / SL / SG | FB | | G | |
| | | IP | CI | | Olmesartan Plus Sandoz 40
mg/25 mg | 98 | 51.08 | 72.00 | 10 % | | Coated tablets: 2 Active Agents | Sandoz
Pharmaceuticals AG | B / SL / SG | FB | | G | |
| | | IP | CI | | Olmesartan-HCT-Mepha Teva
20/12.5 mg | 28 | 13.46 | 31.05 | 10 % | | Coated tablets: Hydrochlorothiazidum 12.5 mg | Mepha Pharma AG | B / SL / SG | FB | | G | |
| | | IP | | | Olmesartan-HCT-Mepha Teva
40/12.5 mg | 28 | 15.42 | 33.25 | 10 % | | Coated tablets: Hydrochlorothiazidum 12.5 mg | Mepha Pharma AG | B / SL / SG | FB | | G | |
| | | IP | CI | | Olmesartan-HCT-Mepha Teva
20/12.5 mg | 98 | 40.04 | 59.95 | 10 % | | Coated tablets: Hydrochlorothiazidum 12.5 mg | Mepha Pharma AG | B / SL / SG | FB | | G | |
| | | IP | | | Olmesartan-HCT-Mepha Teva
40/12.5 mg | 98 | 51.08 | 72.00 | 10 % | | Coated tablets: Hydrochlorothiazidum 12.5 mg | Mepha Pharma AG | B / SL / SG | FB | | G | |
| | | IP | | | Olmesartan-HCT-Mepha Teva
20/25 mg | 28 | 13.46 | 31.05 | 10 % | | Coated tablets: Hydrochlorothiazidum 25 mg | Mepha Pharma AG | B / SL / SG | FB | | G | |
| | | IP | | | Olmesartan-HCT-Mepha Teva
40/25 mg | 28 | 17.18 | 35.10 | 10 % | | Coated tablets: Hydrochlorothiazidum 25 mg | Mepha Pharma AG | B / SL / SG | FB | | G | |
| | | IP | | | Olmesartan-HCT-Mepha Teva
20/25 mg | 98 | 40.04 | 59.95 | 10 % | | Coated tablets: Hydrochlorothiazidum 25 mg | Mepha Pharma AG | B / SL / SG | FB | | G | |
| | | IP | | | Olmesartan-HCT-Mepha Teva
40/25 mg | 98 | 51.08 | 72.00 | 10 % | | Coated tablets: Hydrochlorothiazidum 25 mg | Mepha Pharma AG | B / SL / SG | FB | | G | |
| | SIP | IP | CI | | Olmetec Plus 20/12,5 | 50 Tablet(s) | PR | PR | k.A. | | Coated tablets: 2 Active Agents | Daiichi Sankyo
(Schweiz) AG | B | FB | | G | |
| | SIP | IP | CI | | Olmetec Plus 20/25 | 50 Tablet(s) | PR | PR | k.A. | | Coated tablets: 2 Active Agents | Daiichi Sankyo
(Schweiz) AG | B | FB | | G | |
| | SIP | IP | CI | | Olmetec Plus 40/12,5 | 50 Tablet(s) | PR | PR | k.A. | | Coated tablets: 2 Active Agents | Daiichi Sankyo
(Schweiz) AG | B | FB | | G | |
| | SIP | IP | CI | | Olmetec Plus 40/25 | 50 Tablet(s) | PR | PR | k.A. | | Coated tablets: 2 Active Agents | Daiichi Sankyo
(Schweiz) AG | B | FB | | G | |
| | | IP | CI | | Votum plus 20/12.5 | 50 Tablet(s) | PR | PR | k.A. | | Coated tablets: 2 Active Agents | A. Menarini GmbH | B | FB | | G | |
| | | IP | CI | | Votum plus 20/25 | 50 Tablet(s) | PR | PR | k.A. | | Coated tablets: 2 Active Agents | A. Menarini GmbH | B | FB | | G | |
| | | IP | CI | | Votum plus 40/12.5 | 50 Tablet(s) | PR | PR | k.A. | | Coated tablets: 2 Active Agents | A. Menarini GmbH | B | FB | | G | |
| | | IP | CI | | Votum plus 40/25 | 50 Tablet(s) | PR | PR | k.A. | | Coated tablets: 2 Active Agents | A. Menarini GmbH | B | FB | | G | |
